Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials

Lancet

Volumn 356, Issue 9246, 2000, Pages 1949-1954

  Pahor, Marco ^a,f   Psaty, Bruce M ^c,d   Alderman, Michael H ^e   Applegate, William B ^a   Williamson, Jeff D ^a   Cavazzini, Chiara ^a   Furberg, Curt D ^b  

^a Sticht Center on Aging   (United States)

^b Department of Public Health Sciences ^*

^c WAKE FOREST UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; NIFEDIPINE; NISOLDIPINE; PINDOLOL; TRICHLORMETHIAZIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034627164     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03306-7     Document Type: Article

References (27)

1. Health outcomes associated with antihypertensive therapies used as first-line agents: A systematic review and meta-analysis
2. The risk of myocardial infarction associated with antihypertensive drug therapies
3. Long-term survival and use of antihypertensive medications in older persons
4. Effects of an angiotensin-converting-enzyme ramipril, ramipril on cardiovascular events in high-risk patients
5. Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone in Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT): Preliminary results
6. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events randomized Trial in patients with hypertension and NIDDM
7. The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with non-insulin-dependent diabetes and hypertension
8. Differences between blood-pressure lowering drugs
9. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension study (TOMHS)
10. Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL)
11. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal In Hypertension Treatment (INSIGHT)
12. Final outcome results of the Multicenter Isradipine Diuretic Athersderosis Study (MIDAS): A randomized controlled trial
13. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives
14. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
15. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study
16. Clinical results of the Verapamil in Hypertension and Atherosclerosis Study
17. Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells
18. Role of cytokines in the mechanism of action of amlodipine: The PRAISE Heart Failure Trial (Prospective Randomized Amlodipine Survival Evaluation)
19. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension
20. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
21. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
22. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients
23. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
24. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
25. Calcium-channel blockade and incidence of cancer in aged populations
26. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial
27. Rationale and design for the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT)